"Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Pharmaceutics

• Publication date

  2015-05-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/acs.molpharmaceut.5b00114PMID 26020100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioreducible polymers as a determining factor for polyplex decomplexation rate and transfection.

  2013cited by this paper
• Linear polyethylenimine produced by partial acid hydrolysis of poly(2-ethyl-2-oxazoline) for DNA and siRNA delivery in vitro

  2013cited by this paper
• Development of Degradable, pH‐Sensitive Star Vectors for Enhancing the Cytoplasmic Delivery of Nucleic Acids

  2013cited by this paper
• Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells.

  2013cited by this paper
• RhoC Impacts the Metastatic Potential and Abundance of Breast Cancer Stem Cells

  2012cited by this paper
• PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells

  2011cited by this paper
• Rac and Rho GTPases in cancer cell motility control

  2010cited by this paper
• Degradable, pH-sensitive, membrane-destabilizing, comb-like polymers for intracellular delivery of nucleic acids.

  2010cited by this paper
• Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers

  2010cited by this paper
• N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex.

  2009cited by this paper
• Alkylcarboxylate grafting to polyethylenimine: a simple approach to producing a DNA nanocarrier with low toxicity

  2009cited by this paper
• A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector.

  2009cited by this paper
• Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification*

  2008cited by this paper
• Metastatic cancer cell.

  2008cited by this paper
• Evaluation of Two Cationic Delivery Systems for siRNA

  2007cited by this paper
• In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

  2007cited by this paper
• Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers.

  2005cited by this paper
• In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line

  2005cited by this paper
• Models of epithelial–mesenchymal transition

  2005cited by this paper
• Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

  2005cited by this paper
• Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

  2005cited by this paper
• RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

  2005cited by this paper
• RhoC Induces Differential Expression of Genes Involved in Invasion and Metastasis in MCF10A Breast Cells

  2004cited by this paper
• Cell Migration: Integrating Signals from Front to Back

  2003cited by this paper
• Drug Delivery and Transport to Solid Tumors

  2003cited by this paper
• Rho GTPases in cell biology

  2002cited by this paper
• RHO–GTPases and cancer

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• RhoB Is Dispensable for Mouse Development, but It Modifies Susceptibility to Tumor Formation as Well as Cell Adhesion and Growth Factor Signaling in Transformed Cells

  2001cited by this paper
• Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes

  2000cited by this paper
• RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

  2000cited by this paper
• Nm23, Breast Differentiation, and Cancer Metastasis

  1999cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

  1995cited by this paper
• Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia.

  1995cited by this paper
• Small GTP-binding proteins and the regulation of the actin cytoskeleton.

  1994cited by this paper
• Low molecular weight GTP-binding proteins: molecular switches regulating diverse cellular functions.

  1994cited by this paper
• Biological applications of atomic force microscopy.

  1994cited by this paper
• The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

  1992cited by this paper

• Enhanced In Vitro and In Vivo Autophagy Suppression via LC3 siRNA-Loaded "Smart" Nanoparticles and Doxorubicin Combination Therapy in Triple Negative Breast Cancer.

  2025cites this paper
• PEGylated Reduced Graphene Oxide as Nanoplatform for Targeted Gene and Drug Delivery

  2023cites this paper
• Targeting Cancer by Using Nanoparticles to Modulate RHO GTPase Signaling.

  2022cites this paper
• Cyclodextrin based natural nanostructured carbohydrate polymers as effective non-viral siRNA delivery systems for cancer gene therapy.

  2020cites this paper
• Carbohydrates: potential sweet tools against cancer.

  2020cites this paper
• RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.

  2019cites this paper
• pH-Responsive Polymers: Properties, Synthesis, and Applications

  2019cites this paper
• Effects of RhoC downregulation on the angiogenesis characteristics of myeloma vascular endothelial cells

  2019cites this paper
• RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target

  2019cites this paper
• Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti‐RhoC silencing RNA and presentation of EPPT1 peptide on “smart” particles

  2018cites this paper
• Targeting nanocarriers containing antisense oligonucleotides to cancer cell

  2017cites this paper
• Nanoparticles for imaging and treatment of metastatic breast cancer

  2017cites this paper
• Progress in nonviral gene therapy for breast cancer and what comes next?

  2017cites this paper
• Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer

  2017cites this paper
• DNA/RNA-based formulations for treatment of breast cancer

  2017cites this paper
• Progress in gene therapy for breast cancer and what comes next ?

  2017cites this paper
• Influence of siRNA Loaded Nanoparticles on the Metastasis and Growth Rate of Cancer Cell Lines

  2017cites this paper
• Functionalized non-viral cationic vectors for effective siRNA induced cancer therapy

  2017cites this paper
• In vivo inhibitory effect of lentivirus-mediated RNA interference targeting RhoC on growth of SKOV3 cells

  2017cites this paper
• Advances of cyclodextrin polymers for the delivery of biotech drugs

  2016cites this paper
• Drug Carrier Systems Based on Cyclodextrin Supramolecular Assemblies and Polymers: Present and Perspectives.

  2016cites this paper
• Title : Elastin-like recombinamers as smart drug delivery systems

  2015cites this paper